Patents Assigned to Theranos, Inc.
  • Patent number: 9051599
    Abstract: Reagents, assays, methods, kits, devices, and systems for rapid measurement of cholesterol and cholesterol sub-fractions from a blood sample are provided. Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol can be measured in a single assay using kinetic measurements, under conditions in which cholesterol sub-species are converted to a detectable product at distinct rates. The detectable product is measured at different times after assay initiation. A lipase, cholesterol esterase, cholesterol oxidase and a peroxidase may be used together to produce colored product in amounts directly proportional to the quantity of cholesterol converted. Methods for calculating very-low density lipoprotein cholesterol levels by further including triglyceride measurements are disclosed.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: June 9, 2015
    Assignee: Theranos, Inc.
    Inventors: Douglas Matje, Ian Gibbons, Paul Patel, Elizabeth A. Holmes
  • Patent number: 9012163
    Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.
    Type: Grant
    Filed: July 24, 2014
    Date of Patent: April 21, 2015
    Assignee: Theranos, Inc.
    Inventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
  • Patent number: 8984932
    Abstract: Devices and methods are described for measuring formed blood component sedimentation rate. Some of the methods may use (1) centrifugal techniques for separating red blood cells from plasma and (2) video and/or still imaging capability. Both may be used alone or in combination to accelerate formed blood component sedimentation and to measure its rate. In one example, the method may advantageously enable rapid measurement of sedimentation rate using small blood sample volumes. Automated image analysis can be used to determine both sedimentation rate and hematocrit. Automated techniques may be used to compensate for effects of hematocrit on uncorrected sedimentation rate data.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: March 24, 2015
    Assignee: Theranos, Inc.
    Inventors: Mark Dayel, Samartha Anekal, Elizabeth A. Holmes
  • Publication number: 20150073815
    Abstract: In one embodiment, a method is provided comprising displaying a laboratory test menu on a mobile computing device, where the test menu is variable-based on geographic location; selecting one or more tests from said test menu; and using the mobile computing device to send a laboratory test request to a server.
    Type: Application
    Filed: September 6, 2013
    Publication date: March 12, 2015
    Applicant: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ramesh Balwani
  • Patent number: 8883518
    Abstract: The present invention provides fluidic devices and systems that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: November 11, 2014
    Assignee: Theranos, Inc.
    Inventors: Shaunak Roy, Melissa Takahashi, Ian Gibbons, Edmond Ku, Thanh Dang, Tammy Burd, Adam Vollmer, Elizabeth A. Holmes
  • Publication number: 20140329259
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Application
    Filed: May 6, 2014
    Publication date: November 6, 2014
    Applicant: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Shaunak Roy, Ian Gibbons, Shize Daniel Qi, Edmond Ku, Chris Todd, Melissa Takahashi, Bruce Johnson, Jeff Fenton, Keith Moravick, Uwe Springborn, Anthony Delacruz
  • Publication number: 20140317005
    Abstract: Methods, devices, and systems for the secure transport of material are provided. A transported material may be a biological material, such as a biological sample. Material is only transferred to a courier having a unique, single-use authorization code. Authorization codes are provided to a courier only upon arrival at a proper location and at a designated time. Courier identification or code confirmation or authorization may also be required. Identification or other confirmation regarding a custodian, material to be transferred, or both, may be required. Courier images, custodian images, or both, may be required. An authorization code may include a bar code, a number, a letter, or other symbol or code. An authorization code, an image, route information, and other information may be communicated by cell-phone, WiFi, Bluetooth, or other link. Transport containers with temperature sensors and communication links, and storage containers with light sensors, memory, and communication links are provided.
    Type: Application
    Filed: April 22, 2014
    Publication date: October 23, 2014
    Applicant: Theranos, Inc.
    Inventor: Sunny Balwani
  • Publication number: 20140308689
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Application
    Filed: May 22, 2014
    Publication date: October 16, 2014
    Applicant: Theranos, Inc.
    Inventors: Ian Gibbons, Shaunak Roy, Edmond Ku
  • Patent number: 8862750
    Abstract: Methods and systems are provided for connecting an electronic device to a network. In some situations, the electronic device connects to a first network provider and pings a first server having a static internet protocol address and a second server having a dedicated uniform resource locator. If the electronic device receives a response from the first and second server, the electronic device maintains its connection to the first network provider. Otherwise, the electronic device connects to a second network provider and pings the first and second servers.
    Type: Grant
    Filed: February 11, 2013
    Date of Patent: October 14, 2014
    Assignee: Theranos, Inc.
    Inventor: Sunny Balwani
  • Patent number: 8862448
    Abstract: The present invention provides an integrated health care surveillance and monitoring system that provides real-time sampling, modeling, analysis, and recommended interventions. The system can be used to monitor infectious and chronic diseases. When faced with outbreak of an infectious disease agent, e.g., influenza virus, the system can identify active cases through pro-active sampling in high risk locations, such as schools or crowded commercial areas. The system can notify appropriate entities, e.g., local, regional and national governments, when an event is detected, thereby allowing for proactive management of a possible outbreak. The system also predicts the best response for deployment of scarce resources.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: October 14, 2014
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Daniel L. Young, Seth G. Michelson
  • Publication number: 20140296089
    Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
    Type: Application
    Filed: February 18, 2014
    Publication date: October 2, 2014
    Applicant: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Sunny Balwani, Michael Chen, John K. Frankovich, Gary Frenzel, Surekha Gangakhedkar, Samartha Anekal, Adrit Lath, Alexander Loo, Chinmay Pangarkar, Paul Patel, Joy Roy, Timothy Smith, Daniel Young, Ian Gibbons
  • Patent number: 8840838
    Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: September 23, 2014
    Assignee: Theranos, Inc.
    Inventors: Elizabeth Holmes, John Kent Frankovich
  • Patent number: 8841076
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: September 23, 2014
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Timothy M. Kemp, John Howard, Shaunak Roy
  • Publication number: 20140272938
    Abstract: Devices, systems and methods including a sonicator for sample preparation are provided. A sonicator may be used to mix, resuspend, aerosolize, disperse, disintegrate, or de-gas a solution. A sonicator may be used to disrupt a cell, such as a pathogen cell in a sample. Sample preparation may include exposing pathogen-identifying material by sonication to detect, identify, or measure pathogens. A sonicator may transfer ultrasonic energy to the sample solution by contacting its tip to an exterior wall of a vessel containing the sample. Multipurpose devices including a sonicator also include further components for additional actions and assays. Devices, and systems comprising such devices, may communicate with a laboratory or other devices in a system for sample assay and analysis. Methods utilizing such devices and systems are provided. The improved sample preparation devices, systems and methods are useful for analyzing samples, e.g. for diagnosing patients suffering from infection by pathogens.
    Type: Application
    Filed: March 10, 2014
    Publication date: September 18, 2014
    Applicant: Theranos, Inc.
    Inventors: Alexander Loo, Elizabeth A. Holmes
  • Publication number: 20140273102
    Abstract: Fusion proteins having thermostable blunt-end ligase activity are provided. Blunt-end ligases are useful for DNA amplification, sequencing, production of recombinant DNA and recombinant fusion proteins, and other purposes. These thermostable blunt-end DNA ligases are useful in ligation schemes which include, e.g., an incubation at about 60-65° C. or higher, or as high as about 94° C., or at other temperatures. The ligases disclosed herein may enable high temperature blunt-end ligation without need for molecular crowding agents, and so may be useful for many nucleic acid ligation-amplification schemes, e.g., ones which operate at a uniform temperature (e.g., at about 60° C. or higher), including ones which require temperature cycling, e.g., from about 94° C. to about 60° C. (or higher) for one, two, three, or more cycles.
    Type: Application
    Filed: March 15, 2014
    Publication date: September 18, 2014
    Applicant: Theranos, Inc.
    Inventor: Frederick Christians
  • Publication number: 20140273188
    Abstract: Methods, devices, systems, and apparatuses are provided for the image analysis of measurement of biological samples.
    Type: Application
    Filed: January 22, 2014
    Publication date: September 18, 2014
    Applicant: Theranos, Inc.
    Inventors: Karan Mohan, Chinmay Pangarkar, James Wasson
  • Patent number: 8822167
    Abstract: The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: September 2, 2014
    Assignee: Theranos, Inc.
    Inventors: Tammy Burd, Ian Gibbons, Elizabeth A. Holmes, Gary Frenzel, Anthony Joseph Nugent
  • Patent number: D719302
    Type: Grant
    Filed: September 24, 2013
    Date of Patent: December 9, 2014
    Assignee: Theranos, Inc.
    Inventor: Pey-Jiun Ko
  • Patent number: D729379
    Type: Grant
    Filed: September 10, 2013
    Date of Patent: May 12, 2015
    Assignee: Theranos, Inc.
    Inventor: Pey-Jiun Ko
  • Patent number: D732686
    Type: Grant
    Filed: September 8, 2013
    Date of Patent: June 23, 2015
    Assignee: Theranos, Inc.
    Inventor: Clarissa Lui